1992•The Chinese Journal of Clinical PharmacologyRequires access

S-MEPHENYTOIN HYDROXYLATION POLYMORPHISM AND ITS RELATION TO DEBRISOQUINE HYDROXYLATION PHENOTYPE IN NATIVE NORMAL CHINESE SUBJECTS

Lou Ya

Open publisher page 0 citations

Abstract

Mephenytoin (100mg) and debrisoquine (10mg) were coadministered orally. Theratio between the S- and R- enantiomers of mephenytoin and the ration between debrisoquine and 4- hydroxyldebrisouine (metabolic ratio, MR) in 8 h urine were determined by gas chromatography withNPD or PID respectively. These ratios were used as measures of drug hydroxylation capacity. In the137 native normal Chinese subjects the frequency of PMs of s-mephenytoin hydroxylation was foundto be 14.6% (20/137) which is similar to the previously reported results in Japanese population (18-22%), but much higher than that in the Caucasian populations (2.4-5.4%). Thus, we can concludethat there are pronounced differences in the incidence of S-mephenytoin hydroxylation of PMs betweenOriental and Caucasian populations. Our results also showed that there was no relationship between S-mephenytoin and debrisoquine hydroxylation phenotypes in 137 native Chinese subjects. These dis-parate findings demonstrated that the S-mephenytoin and debrisoquine hydroxylases are two differentisozymes of the cytochrome P_(450) family and the independence of two oxidative metabolizing traits.

About this research paper

What this paper is about

Mephenytoin (100mg) and debrisoquine (10mg) were coadministered orally. Theratio between the S- and R- enantiomers of mephenytoin and the ration between debrisoquine and 4- hydroxyldebrisouine (metabolic ratio, MR) in 8 h urine were determined by gas chromatography withNPD or PID respectively. These ratios were used as measures of drug hydroxylation capacity. In the137 native normal Chinese subjects the frequency of PMs of s-mephenytoin hydroxylation was foundto be 14.6% (20/137) which is similar to the previously reported results in Japanese population (18-22%), but much higher than that in the Caucasian populations (2.4-5.4%). Thus, we can concludethat there are pronounced differences in the incidence of S-mephenytoin hydroxylation of PMs betweenOriental and Caucasian populations. Our results also showed that there was no relationship between S-mephenytoin and debrisoquine hydroxylation phenotypes in 137 native Chinese subjects. These dis-parate findings demonstrated that the S-mephenytoin and debrisoquine hydroxylases are two differentisozymes of the cytochrome P_(450) family and the independence of two oxidative metabolizing traits.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Mephenytoin (100mg) and debrisoquine (10mg) were coadministered orally. Theratio between the S- and R- enantiomers of mephenytoin and the ration between debrisoquine and 4- hydroxyldebrisouine (metabolic ratio, MR) in 8 h urine were determined by gas chromatography withNPD or PID respectively. These ratios were used as measures of drug hydroxylation capacity. In the137 native normal Chinese subjects the frequency of PMs of s-mephenytoin hydroxylation was foundto be 14.6% (20/137) which is similar to the previously reported results in Japanese population (18-22%), but much higher than that in the Caucasian populations (2.4-5.4%). Thus, we can concludethat there are pronounced differences in the incidence of S-mephenytoin hydroxylation of PMs betweenOriental and Caucasian populations. Our results also showed that there was no relationship between S-mephenytoin and debrisoquine hydroxylation phenotypes in 137 native Chinese subjects. These dis-parate findings demonstrated that the S-mephenytoin and debrisoquine hydroxylases are two differentisozymes of the cytochrome P_(450) family and the independence of two oxidative metabolizing traits.

Key concepts: Mephenytoin, Debrisoquine, Hydroxylation, CYP2D6, Pharmacogenetics, Chemistry, Biology, Cytochrome P450

Related papers

Back to paper searchBrowse research topicsOriginal source
S-MEPHENYTOIN HYDROXYLATION POLYMORPHISM AND ITS RELATION TO DEBRISOQUINE HYDROXYLATION PHENOTYPE IN NATIVE NORMAL CHINESE SUBJECTS — Research Paper | ScholarLens